Tvardi Therapeutics Faces Investigation Over Significant Stock Losses.

miércoles, 10 de diciembre de 2025, 9:55 am ET1 min de lectura
TVRD--

Faruqi & Faruqi, LLP is investigating potential claims against Tvardi Therapeutics, Inc. following a significant decline in its shares. Investors who suffered significant losses are encouraged to contact Josh Wilson directly at 877-247-4292 or 212-983-9330. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios